ATP5MGP2

Across TCGA pan-cancer cohorts, ATP5MGP2 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of ATP5MGP2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ATP5MGP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5MGP2 is over-expressed in tumor, although a few such as READ and STAD show the opposite, repressed pattern.

COAD, READ, and UCEC are the cancer types where ATP5MGP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5MGP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.782	.005	6	view →
READ	All	II,III,IV	−0.232	<.001	5	view →
UCEC	All	II,III,IV	+0.563	.013	4	view →
LIHC	All	All	+0.073	.010	3	view →
HNSC	Male	III,IV	+0.141	.010	2	view →
STAD	Male	III,IV	−0.395	.013	1	view →
KICH	Female	All	+0.273	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

ATP5MGP2–COAD

Open the COAD breakdown →